Fennec Pharmaceuticals (FENC) Short Interest Ratio & Short Volume → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free FENC Stock Alerts $7.04 -0.08 (-1.12%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Fennec Pharmaceuticals Short Interest DataCurrent Short Volume1,810,000 sharesPrevious Short Volume1,870,000 sharesChange Vs. Previous Month-3.21%Dollar Volume Sold Short$16.62 millionShort Interest Ratio / Days to Cover13.7Last Record DateApril 30, 2024Outstanding Shares27,317,000 sharesFloat Size23,140,000 sharesShort Percent of Float7.82%Today's Trading Volume306,700 sharesAverage Trading Volume132,809 sharesToday's Volume Vs. Average231% Short Selling Fennec Pharmaceuticals ? Sign up to receive the latest short interest report for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatFENC Short Interest Over TimeFENC Days to Cover Over TimeFENC Percentage of Float Shorted Over Time Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… Fennec Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,810,000 shares $16.62 million -3.2%7.8%13.7 $9.18 4/15/20241,870,000 shares $19.32 million +3.3%8.1%14.5 $10.33 3/31/20241,810,000 shares $20.13 million +7.1%9.1%16.4 $11.12 3/15/20241,690,000 shares $16.80 million -1.2%8.5%14.4 $9.94 2/29/20241,710,000 shares $16.19 million -2.3%8.6%13.9 $9.47 2/15/20241,750,000 shares $16.00 million -2.2%8.9%14.8 $9.14 Get the Latest News and Ratings for FENC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,790,000 shares $17.88 million -3.8%9.1%15.3 $9.99 1/15/20241,860,000 shares $19.14 million -7.5%9.5%15.3 $10.29 12/31/20232,010,000 shares $22.55 million -1.5%9.2%15.6 $11.22 12/15/20232,040,000 shares $20.30 million +6.8%9.4%15 $9.95 11/30/20231,910,000 shares $16.43 million -2.6%8.8%19.1 $8.60 11/15/20231,960,000 shares $15.70 million +2.1%9.0%20.9 $8.01 10/31/20231,920,000 shares $13.21 million -0.5%8.7%23 $6.88 10/15/20231,930,000 shares $13.32 million +19.1%8.8%25.4 $6.90 9/30/20231,620,000 shares $12.17 million +1.3%7.4%22.7 $7.51 9/15/20231,600,000 shares $12.69 million -3.0%7.3%27.3 $7.93 8/31/20231,650,000 shares $13.46 million -0.6%7.5%15.2 $8.16 8/15/20231,660,000 shares $13.76 million +0.6%7.6%14.5 $8.29 7/31/20231,650,000 shares $14.70 million -2.9%7.5%13.3 $8.91 7/15/20231,700,000 shares $14.93 million -1.2%7.8%13.8 $8.78 6/30/20231,720,000 shares $15.19 million -1.2%7.9%13.6 $8.83 6/15/20231,740,000 shares $16.84 million +1.2%8.0%12.6 $9.68 5/31/20231,720,000 shares $13.04 million +17.0%7.9%19.1 $7.58 5/15/20231,470,000 shares $11.23 million No Change6.7%17 $7.64 10/31/2022547,400 shares $4.82 million +17.4%2.9%3.6 $8.80 10/15/2022466,300 shares $3.67 million -6.3%2.4%3.3 $7.87 9/30/2022497,800 shares $4.03 million +1.1%2.6%3.9 $8.10 9/15/2022492,200 shares $3.31 million +39.7%2.6%4.3 $6.72 8/31/2022352,300 shares $2.47 million +16.2%1.6%7.1 $7.00 8/15/2022303,100 shares $2.06 million +64.7%1.4%8 $6.79 7/31/2022184,000 shares $1.23 million +18.3%0.9%6.3 $6.68 7/15/2022155,500 shares $1.04 million -1.3%0.7%5.3 $6.72 6/30/2022157,600 shares $879,408.00 -25.5%1.0%5.5 $5.58 6/15/2022211,400 shares $1.19 million -18.0%1.3%7.2 $5.61 5/31/2022257,900 shares $1.47 million -2.7%1.2%8 $5.71 5/15/2022265,100 shares $1.46 million -0.1%1.2%7.5 $5.52 4/30/2022265,300 shares $1.53 million -1.7%1.2%7.2 $5.78 4/15/2022269,800 shares $1.67 million -0.4%1.3%6.8 $6.20 3/31/2022270,800 shares $1.52 million -3.3%N/A5.9 $5.60 3/15/2022279,900 shares $1.46 million -0.7%1.3%4.8 $5.20Must-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… FENC Short Interest - Frequently Asked Questions What is Fennec Pharmaceuticals' current short interest? Short interest is the volume of Fennec Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 1,810,000 shares of FENC short. 7.82% of Fennec Pharmaceuticals' shares are currently sold short. Learn More on Fennec Pharmaceuticals' current short interest. What is a good short interest ratio for Fennec Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FENC shares currently have a short interest ratio of 14.0. Learn More on Fennec Pharmaceuticals's short interest ratio. What is a good short interest percentage for Fennec Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.82% of Fennec Pharmaceuticals' floating shares are currently sold short. Is Fennec Pharmaceuticals' short interest increasing or decreasing? Fennec Pharmaceuticals saw a decrease in short interest during the month of April. As of April 30th, there was short interest totaling 1,810,000 shares, a decrease of 3.2% from the previous total of 1,870,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Fennec Pharmaceuticals' float size? Fennec Pharmaceuticals currently has issued a total of 27,317,000 shares. Some of Fennec Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Fennec Pharmaceuticals currently has a public float of 23,140,000 shares. How does Fennec Pharmaceuticals' short interest compare to its competitors? 7.82% of Fennec Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Fennec Pharmaceuticals: Kodiak Sciences Inc. (3.76%), Century Therapeutics, Inc. (5.00%), Elevation Oncology, Inc. (11.46%), INmune Bio, Inc. (13.54%), Opthea Limited (0.22%), Innate Pharma S.A. (0.10%), Adverum Biotechnologies, Inc. (8.04%), Genfit S.A. (0.18%), Compugen Ltd. (2.25%), Acumen Pharmaceuticals, Inc. (2.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Fennec Pharmaceuticals stock? Short selling FENC is an investing strategy that aims to generate trading profit from Fennec Pharmaceuticals as its price is falling. FENC shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Fennec Pharmaceuticals? A short squeeze for Fennec Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FENC, which in turn drives the price of the stock up even further. How often is Fennec Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FENC, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Kodiak Sciences Short Interest Century Therapeutics Short Interest Elevation Oncology Short Interest INmune Bio Short Interest Opthea Short Interest Innate Pharma Short Interest Adverum Biotechnologies Short Interest Genfit Short Interest Compugen Short Interest Acumen Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FENC) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMost important medical advance in 100 yearsThe Oxford ClubDems have chosen Biden replacement?Paradigm Press